Latest News

Musical instruments can throw skin out of tune


 

FROM SISD 2021

Violin and viola players can pay a price for the music they create: Many suffer from skin irritation and inflammation where the instruments touch their necks and upper bodies. Now, a new literature review offers insight into this common condition, known as “fiddler’s neck.”

A woman plays a violin Hill Street Studios/Stone/Getty Images

“These skin conditions are disfiguring, and they also carry so much psychological burden. Not only are these patients under constant pressure to perform at their maximum at all times, it really is troublesome when there is a barrier between you and performing art that you absolutely love,” lead author Henry Lim, an osteopathic medical student at the University of North Texas Health Science Center at Fort Worth, said in an interview.

Henry Lim, osteopathic medical student at the University of North Texas/Health Science Center at Fort Worth

Henry Lim

The results of the literature review were presented in a poster at the Inaugural Symposium for Inflammatory Skin Disease.

Mr. Lim, who has a special interest in skin, said his own musical experience inspired the research. “Throughout my experience as a violinist, I faced many dermatologic issues because of my violin, and it affected my performance,” he said. “As time went on, I recognized that many other stringed instrumentalists were dealing with similar issues but chose to live with it because it came with the territory.”


One physician told Mr. Lim that he needed to quit in order to permanently treat his skin problems. He didn’t accept this answer and instead launched the literature review with colleagues Marshall Hall, MPH, also an osteopathic medical student with an interest in dermatology, and Sajid Surve, DO, codirector of the UNT Texas Center for Performing Arts Health.

Pages

Recommended Reading

Atopic Dermatitis
MDedge Dermatology
Trial offers first look at how tralokinumab-treated patients weather COVID-19
MDedge Dermatology
1 in 15 patients who start dupilumab may develop conjunctivitis, large analysis finds
MDedge Dermatology
12-month follow-up shows monthly maintenance dose of tralokinumab maintains response in some AD patients
MDedge Dermatology
Survey spotlights the out-of-pocket burden on Blacks with atopic dermatitis
MDedge Dermatology
Ruxolitinib cream for atopic dermatitis found to be effective, safe up to 52 weeks
MDedge Dermatology
Baricitinib found effective for moderate to severe AD out to 52 weeks
MDedge Dermatology
Malignancy risk: Secukinumab shows long-term safety for psoriasis, PsA, ankylosing spondylitis
MDedge Dermatology
Expert shares practical considerations when prescribing dupilumab
MDedge Dermatology
How well do JAK inhibitors work for atopic dermatitis?
MDedge Dermatology